1. Home
  2. OCS vs TIXT Comparison

OCS vs TIXT Comparison

Compare OCS & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • TIXT
  • Stock Information
  • Founded
  • OCS 2003
  • TIXT 2005
  • Country
  • OCS Switzerland
  • TIXT Canada
  • Employees
  • OCS N/A
  • TIXT N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • TIXT EDP Services
  • Sector
  • OCS Health Care
  • TIXT Technology
  • Exchange
  • OCS Nasdaq
  • TIXT Nasdaq
  • Market Cap
  • OCS 1.0B
  • TIXT 812.7M
  • IPO Year
  • OCS N/A
  • TIXT 2021
  • Fundamental
  • Price
  • OCS $19.28
  • TIXT $3.66
  • Analyst Decision
  • OCS Strong Buy
  • TIXT Hold
  • Analyst Count
  • OCS 3
  • TIXT 9
  • Target Price
  • OCS $35.33
  • TIXT $4.17
  • AVG Volume (30 Days)
  • OCS 30.1K
  • TIXT 1.3M
  • Earning Date
  • OCS 05-08-2025
  • TIXT 08-01-2025
  • Dividend Yield
  • OCS N/A
  • TIXT N/A
  • EPS Growth
  • OCS N/A
  • TIXT N/A
  • EPS
  • OCS N/A
  • TIXT N/A
  • Revenue
  • OCS $847,333.00
  • TIXT $2,671,000,000.00
  • Revenue This Year
  • OCS $18.70
  • TIXT $3.61
  • Revenue Next Year
  • OCS $1,059.78
  • TIXT $3.59
  • P/E Ratio
  • OCS N/A
  • TIXT N/A
  • Revenue Growth
  • OCS N/A
  • TIXT N/A
  • 52 Week Low
  • OCS $10.79
  • TIXT $2.13
  • 52 Week High
  • OCS $23.08
  • TIXT $6.86
  • Technical
  • Relative Strength Index (RSI)
  • OCS 51.81
  • TIXT 71.90
  • Support Level
  • OCS $18.64
  • TIXT $2.81
  • Resistance Level
  • OCS $19.73
  • TIXT $3.79
  • Average True Range (ATR)
  • OCS 0.58
  • TIXT 0.16
  • MACD
  • OCS -0.07
  • TIXT 0.07
  • Stochastic Oscillator
  • OCS 36.57
  • TIXT 89.62

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares

TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.

Share on Social Networks: